Clinical Research Directory
Browse clinical research sites, groups, and studies.
Acceptability of Hybrid Closed-loop Systems in Patients Living With Highly Unbalanced Type 1 Diabetes
Sponsor: Centre Hospitalier Sud Francilien
Summary
While closed-loop insulin delivery (CLID) systems demonstrated safety and effectiveness in patients with unbalanced type 1 diabetes (T1D), no studies have included patients with highly and chronically unbalanced diabetes. The investigators conduct a retrospective, observational, and single-center study to evaluate the acceptability, safety, and efficacy of a CLID system in patients living with T1D (≥2 years) with a HbA1c\>11% in the past 12 months and a mean HbA1c \>10% over the past three years. Efficacy was assessed using continuous glucose monitoring parameters.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
66
Start Date
2022-04-01
Completion Date
2023-12-11
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
device
closed-loop insulin
Locations (2)
Penfornis
Corbeil-Essonnes, Centre Hospitalier Sud Francilien, France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France